Efficacy and safety of filgotinib in patients with moderately active rheumatoid arthritis and an inadequate response to methotrexate

Authors

Institutions

Publication Details

Journal
Lara D. Veeken
Published
2024-09-27
DOI
https://doi.org/10.1093/rheumatology/keae486
Citations
2
Primary Topic
Chronic Lymphocytic Leukemia Research
Type
article
Field-Weighted Citation Impact
0.88

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Efficacy and safety of filgotinib in patients with moderately active rheumatoid arthritis and an inadequate response to methotrexate

Edmund Omoruyi, Maya H Buch, Jane Barry, Laura Akroyd et al.
2 citations
Lara D. Veeken
Chronic Lymphocytic Leukemia Research
0.88
article

Efficacy and safety of filgotinib in patients with moderately active rheumatoid arthritis and an inadequate response to methotrexate

Edmund Omoruyi, Maya H Buch, Jane Barry, Laura Akroyd, Christopher J Edwards, Peter C. Taylor, David Walker
article en
2 citations

Abstract

No abstract available for this paper.
Lara D. VeekenVol. 64(4)
Northumbria Healthcare NHS Foundation Trust (GB), Nuffield Orthopaedic Centre (GB), University Hospital Southampton NHS Foundation Trust (GB), University of Oxford (GB), Manchester University NHS Foundation Trust (GB), NIHR Southampton Biomedical Research Centre (GB), NIHR Manchester Biomedical Research Centre (GB), Galapagos (Belgium) (BE)
Gilead Sciences, Galápagos
Good health and well-being
Openalex Percentile: Top 24%
Chronic Lymphocytic Leukemia Research
0.88
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Efficacy and safety of filgotinib in patients with moderately active rheumatoid arthritis and an inadequate response to methotrexate — Edmund Omoruyi, Maya H Buch, et al. · Lara D. Veeken (2024) | TGRS Research Map | TGRS